Generare

Generare is a Paris-based techbio company that focuses on unlocking nature's untapped molecular potential by decoding microbial genomes. The company has developed a proprietary computational biology and high-throughput cloning/sequencing platform to identify, extract, and characterize novel bioactive molecules that have remained largely unexplored in microbial DNA. By systematically mining the estimated 97% of microbial chemistry that has never been screened, Generare aims to build one of the world's largest commercial libraries of evolution-derived compounds. These molecules serve as lead candidates for pharmaceutical and agrochemical applications, including potential therapeutics for oncology, anti-infectives, and immunosuppressants.